Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size, Status and Forecast 2018-2025

Date: Sep 20 2018
|
QYRESEARCH
|
Number of Pages: 91
|
Alternate Text Alternate Text Alternate Text Alternate Text

This report focuses on the global Recurrent Glioblastoma Multiforme (GBM) Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Recurrent Glioblastoma Multiforme (GBM) Treatment development in United States, Europe and China.

Recurrent glioblastoma multiforme is the most aggressive cancer that begins within the brain.
The increasing incidence of seizure is expected to drive the recurrent glioblastoma multiforme treatment market.
In 2017, the global Recurrent Glioblastoma Multiforme (GBM) Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study
Astrazeneca
Roche
GlaxoSmithKline
Merck
Pfizer
AngioChem
Vascular Biogeneics
...

Market segment by Type, the product can be split into
Oral Medications
Temozolomide
Radiosensitizers
Nitrosoureas Drugs
Radiation Therapy
Chemotherapy

Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgical Centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Recurrent Glioblastoma Multiforme (GBM) Treatment status, future forecast, growth opportunity, key market and key players.
To present the Recurrent Glioblastoma Multiforme (GBM) Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Recurrent Glioblastoma Multiforme (GBM) Treatment are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents
1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
           1.4.1 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Growth Rate by Type (2013-2025)
           1.4.2 Oral Medications
           1.4.3 Temozolomide
           1.4.4 Radiosensitizers
           1.4.5 Nitrosoureas Drugs
           1.4.6 Radiation Therapy
           1.4.7 Chemotherapy
    1.5 Market by Application
           1.5.1 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Application (2013-2025)
           1.5.2 Hospitals
           1.5.3 Clinics
           1.5.4 Ambulatory Surgical Centers
    1.6 Study Objectives
    1.7 Years Considered
2 Global Growth Trends
    2.1 Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size
    2.2 Recurrent Glioblastoma Multiforme (GBM) Treatment Growth Trends by Regions
           2.2.1 Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Regions (2013-2025)
           2.2.2 Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Regions (2013-2018)
    2.3 Industry Trends
           2.3.1 Market Top Trends
           2.3.2 Market Drivers
           2.3.3 Market Opportunities
3 Market Share by Key Players
    3.1 Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Manufacturers
           3.1.1 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue by Manufacturers (2013-2018)
           3.1.2 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Share by Manufacturers (2013-2018)
           3.1.3 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Concentration Ratio (CR5 and HHI)
    3.2 Recurrent Glioblastoma Multiforme (GBM) Treatment Key Players Head office and Area Served
    3.3 Key Players Recurrent Glioblastoma Multiforme (GBM) Treatment Product/Solution/Service
    3.4 Date of Enter into Recurrent Glioblastoma Multiforme (GBM) Treatment Market
    3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
    4.1 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type (2013-2018)
    4.2 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application (2013-2018)
5 United States
    5.1 United States Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size (2013-2018)
    5.2 Recurrent Glioblastoma Multiforme (GBM) Treatment Key Players in United States
    5.3 United States Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type
    5.4 United States Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application
6 Europe
    6.1 Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size (2013-2018)
    6.2 Recurrent Glioblastoma Multiforme (GBM) Treatment Key Players in Europe
    6.3 Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type
    6.4 Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application
7 China
    7.1 China Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size (2013-2018)
    7.2 Recurrent Glioblastoma Multiforme (GBM) Treatment Key Players in China
    7.3 China Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type
    7.4 China Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application
8 Japan
    8.1 Japan Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size (2013-2018)
    8.2 Recurrent Glioblastoma Multiforme (GBM) Treatment Key Players in Japan
    8.3 Japan Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type
    8.4 Japan Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application
9 Southeast Asia
    9.1 Southeast Asia Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size (2013-2018)
    9.2 Recurrent Glioblastoma Multiforme (GBM) Treatment Key Players in Southeast Asia
    9.3 Southeast Asia Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type
    9.4 Southeast Asia Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application
10 India
    10.1 India Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size (2013-2018)
    10.2 Recurrent Glioblastoma Multiforme (GBM) Treatment Key Players in India
    10.3 India Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type
    10.4 India Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application
11 Central & South America
    11.1 Central & South America Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size (2013-2018)
    11.2 Recurrent Glioblastoma Multiforme (GBM) Treatment Key Players in Central & South America
    11.3 Central & South America Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type
    11.4 Central & South America Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application
12 International Players Profiles
    12.1 Astrazeneca
           12.1.1 Astrazeneca Company Details
           12.1.2 Company Description and Business Overview
           12.1.3 Recurrent Glioblastoma Multiforme (GBM) Treatment Introduction
           12.1.4 Astrazeneca Revenue in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2013-2018)
           12.1.5 Astrazeneca Recent Development
    12.2 Roche
           12.2.1 Roche Company Details
           12.2.2 Company Description and Business Overview
           12.2.3 Recurrent Glioblastoma Multiforme (GBM) Treatment Introduction
           12.2.4 Roche Revenue in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2013-2018)
           12.2.5 Roche Recent Development
    12.3 GlaxoSmithKline
           12.3.1 GlaxoSmithKline Company Details
           12.3.2 Company Description and Business Overview
           12.3.3 Recurrent Glioblastoma Multiforme (GBM) Treatment Introduction
           12.3.4 GlaxoSmithKline Revenue in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2013-2018)
           12.3.5 GlaxoSmithKline Recent Development
    12.4 Merck
           12.4.1 Merck Company Details
           12.4.2 Company Description and Business Overview
           12.4.3 Recurrent Glioblastoma Multiforme (GBM) Treatment Introduction
           12.4.4 Merck Revenue in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2013-2018)
           12.4.5 Merck Recent Development
    12.5 Pfizer
           12.5.1 Pfizer Company Details
           12.5.2 Company Description and Business Overview
           12.5.3 Recurrent Glioblastoma Multiforme (GBM) Treatment Introduction
           12.5.4 Pfizer Revenue in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2013-2018)
           12.5.5 Pfizer Recent Development
    12.6 AngioChem
           12.6.1 AngioChem Company Details
           12.6.2 Company Description and Business Overview
           12.6.3 Recurrent Glioblastoma Multiforme (GBM) Treatment Introduction
           12.6.4 AngioChem Revenue in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2013-2018)
           12.6.5 AngioChem Recent Development
    12.7 Vascular Biogeneics
           12.7.1 Vascular Biogeneics Company Details
           12.7.2 Company Description and Business Overview
           12.7.3 Recurrent Glioblastoma Multiforme (GBM) Treatment Introduction
           12.7.4 Vascular Biogeneics Revenue in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2013-2018)
           12.7.5 Vascular Biogeneics Recent Development
13 Market Forecast 2018-2025
    13.1 Market Size Forecast by Regions
    13.2 United States
    13.3 Europe
    13.4 China
    13.5 Japan
    13.6 Southeast Asia
    13.7 India
    13.8 Central & South America
    13.9 Market Size Forecast by Product (2018-2025)
    13.10 Market Size Forecast by Application (2018-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
    15.1 Research Methodology
           15.1.1 Methodology/Research Approach
                 15.1.1.1 Research Programs/Design
                 15.1.1.2 Market Size Estimation
                 12.1.1.3 Market Breakdown and Data Triangulation
           15.1.2 Data Source
                 15.1.2.1 Secondary Sources
                 15.1.2.2 Primary Sources
    15.2 Disclaimer
    15.3 Author Details

List of Tables and Figures
Table Recurrent Glioblastoma Multiforme (GBM) Treatment Key Market Segments
Table Key Players Recurrent Glioblastoma Multiforme (GBM) Treatment Covered
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Growth Rate by Type 2013-2025 (Million US$)
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Type 2013-2025
Figure Oral Medications Figures
Table Key Players of Oral Medications
Figure Temozolomide Figures
Table Key Players of Temozolomide
Figure Radiosensitizers Figures
Table Key Players of Radiosensitizers
Figure Nitrosoureas Drugs Figures
Table Key Players of Nitrosoureas Drugs
Figure Radiation Therapy Figures
Table Key Players of Radiation Therapy
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Growth by Application 2013-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Recurrent Glioblastoma Multiforme (GBM) Treatment Report Years Considered
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2013-2025 (Million US$)
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size and Growth Rate 2013-2025 (Million US$)
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Regions 2013-2025 (Million US$)
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Regions 2013-2018 (Million US$)
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Regions 2013-2018
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Regions 2013-2018
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Regions 2018
Table Market Top Trends
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue by Manufacturers (2013-2018) (Million US$)
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Manufacturers (2013-2018)
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Manufacturers in 2018
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Recurrent Glioblastoma Multiforme (GBM) Treatment Product/Solution/Service
Table Date of Enter into Recurrent Glioblastoma Multiforme (GBM) Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type (2013-2018) (Million US$)
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Share by Type (2013-2018)
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Type (2013-2018)
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application (2013-2018) (Million US$)
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Share by Application (2013-2018)
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Market Share by Application (2013-2018)
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Share by Application in 2017
Figure United States Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2013-2018 (Million US$)
Table United States Key Players Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue (2017-2018) (Million US$)
Table United States Key Players Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share (2017-2018)
Table United States Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type (2013-2018) (Million US$)
Table United States Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Type (2013-2018)
Table United States Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application (2013-2018) (Million US$)
Table United States Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Application (2013-2018)
Figure Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2013-2018 (Million US$)
Table Europe Key Players Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue (2017-2018) (Million US$)
Table Europe Key Players Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share (2017-2018)
Table Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type (2013-2018) (Million US$)
Table Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Type (2013-2018)
Table Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application (2013-2018) (Million US$)
Table Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Application (2013-2018)
Figure China Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2013-2018 (Million US$)
Table China Key Players Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue (2017-2018) (Million US$)
Table China Key Players Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share (2017-2018)
Table China Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type (2013-2018) (Million US$)
Table China Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Type (2013-2018)
Table China Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application (2013-2018) (Million US$)
Table China Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Application (2013-2018)
Figure Japan Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2013-2018 (Million US$)
Table Japan Key Players Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue (2017-2018) (Million US$)
Table Japan Key Players Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share (2017-2018)
Table Japan Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type (2013-2018) (Million US$)
Table Japan Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Type (2013-2018)
Table Japan Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application (2013-2018) (Million US$)
Table Japan Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Application (2013-2018)
Figure Southeast Asia Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2013-2018 (Million US$)
Table Southeast Asia Key Players Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue (2017-2018) (Million US$)
Table Southeast Asia Key Players Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share (2017-2018)
Table Southeast Asia Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type (2013-2018) (Million US$)
Table Southeast Asia Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Type (2013-2018)
Table Southeast Asia Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application (2013-2018) (Million US$)
Table Southeast Asia Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Application (2013-2018)
Figure India Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2013-2018 (Million US$)
Table India Key Players Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue (2017-2018) (Million US$)
Table India Key Players Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share (2017-2018)
Table India Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type (2013-2018) (Million US$)
Table India Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Type (2013-2018)
Table India Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application (2013-2018) (Million US$)
Table India Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Application (2013-2018)
Figure Central & South America Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size 2013-2018 (Million US$)
Table Central & South America Key Players Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue (2017-2018) (Million US$)
Table Central & South America Key Players Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share (2017-2018)
Table Central & South America Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Type (2013-2018) (Million US$)
Table Central & South America Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Type (2013-2018)
Table Central & South America Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application (2013-2018) (Million US$)
Table Central & South America Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share by Application (2013-2018)
Table Astrazeneca Company Details
Table Astrazeneca Revenue in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2013-2018) (Million US$)
Figure Astrazeneca Revenue Growth Rate in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2013-2018)
Table Astrazeneca Recent Development
Table Roche Company Details
Table Roche Revenue in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2013-2018)(Million US$)
Figure Roche Revenue Growth Rate in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2013-2018)
Table Roche Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2013-2018)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2013-2018)
Table GlaxoSmithKline Recent Development
Table Merck Company Details
Table Merck Revenue in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2013-2018)(Million US$)
Figure Merck Revenue Growth Rate in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2013-2018)
Table Merck Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2013-2018)(Million US$)
Figure Pfizer Revenue Growth Rate in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2013-2018)
Table Pfizer Recent Development
Table AngioChem Company Details
Table AngioChem Revenue in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2013-2018)(Million US$)
Figure AngioChem Revenue Growth Rate in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2013-2018)
Table AngioChem Recent Development
Table Vascular Biogeneics Company Details
Table Vascular Biogeneics Revenue in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2013-2018)(Million US$)
Figure Vascular Biogeneics Revenue Growth Rate in Recurrent Glioblastoma Multiforme (GBM) Treatment Business (2013-2018)
Table Vascular Biogeneics Recent Development
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Regions (Million US$) 2018-2025
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Share by Regions (2018-2025)
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Share by Regions in 2025
Figure United States Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Forecast (2018-2025)(Million USD)
Figure Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Forecast (2018-2025)(Million USD)
Figure China Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Forecast (2018-2025)(Million USD)
Figure Japan Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Forecast (2018-2025)(Million USD)
Figure Southeast Asia Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Forecast (2018-2025)(Million USD)
Figure India Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Forecast (2018-2025)(Million USD)
Figure Central & South America Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Forecast (2018-2025)(Million USD)
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Product (2018-2025) (Million US$)
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Product (2018-2025)
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Product in 2025
Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application (2018-2025) (Million US$)
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application (2018-2025)
Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Electronic files(PDF) of market research reports will be dispatched within 12 to 24 hours. (Mon-Fri IST)

Select License Type

Need Help?
+
SUBSCRIBE TO THE MAILING TO KEEP UP WITH LATEST NEWS AND UPDATES
x
We use cookies to deliver the best possible experience on our website by improving the user experience, personalizing your visit, and compiling aggregate statistics. By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more visit our Privacy policy page.